Trial Profile
A phase I study of IRL752
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2017
At a glance
- Drugs IRL 752 (Primary)
- Indications Attention-deficit hyperactivity disorder; Dementia
- Focus Adverse reactions
- 27 Nov 2017 New trial record